Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news
Where Medical Sales Professionals...Click

Home | Contact | Advertise | News | RSS | Jobs 

Home Manager Resources Sales Executive Resources Trainee & Graduate Resources Nurse Resources Medical sales, pharmaceutical sales & healthcare sales jobs

Medical, Pharmaceutical & Healthcare sales jobs

 




Home » News » 01/06 » Aspirin cuts stroke risk in women, heart attacks in men

Aspirin cuts stroke risk in women, heart attacks in men

Date published: 18/01/2006

Aspirin reduces cardiovascular risks differently in men and women, lowering the risk of heart attack more in men and the risk of stroke more in women, a new study has revealed. Although the effect of aspirin on cardiovascular events is widely acknowledged, the research from scientists at Duke University Medical Centre in the US, suggests that the major reasons for the risk reduction differed in both sexes.

The use of aspirin also caused an increased risk of bleeding among both sexes. In the study of over 95,000 patients, the researchers used a low-dose of aspirin versus a placebo to measure the level of cardiovascular risk.

They found that aspirin produced a 12 per cent reduction in cardiovascular risk for women, and a 14 per cent reduction for men.

"This is good news because many of the past studies of the effect of aspirin in preventing cardiovascular events looked only at men, so physicians were reluctant to prescribe aspirin for women because there was little data," said lead author Dr Jeffrey Berger.

"But now, the combined data of recent trials involving women demonstrates that women can benefit just as much from aspirin therapy as men," she added.

© Adfero Ltd

Disclaimer

AllAboutMedicalSales excludes any warranty, express or implied, as to the quality, accuracy, timeliness, completeness or fitness for a particular purpose of this briefing. AllAboutMedicalSales will not be liable for any claims, penalties, losses, damages, costs, or expenses arising from the use of or inability to use this briefing or from any unauthorised access to or alteration of the Briefing. AllAboutMedicalSales makes no warranty that the contents of this briefing are compatible with all computer systems and browsers.

Home | Free SMS | Personality Test | Curriculum Vitae | Jobs | Advertise | Pharmaceutical News | NHS News | Pharmaceutical news rss